Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Sharman JP, Laurenti L, Ferrant E, Casado Montero LF, Mulligan SP, Harrup R, Opat S, Ibatici A, Marasca R, Sportoletti P, Thadani-Mulero M, Cazares O, Huang W, Jiang Y, Clark E, Jin HY, Boyer M, Morschhauser F

Open source

DOI: 10.1182/blood.2025030630
Published: 2026 Jun 11
Container: Blood
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025030630,
  title = {Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.},
  author = {Sharman JP and Laurenti L and Ferrant E and Casado Montero LF and Mulligan SP and Harrup R and Opat S and Ibatici A and Marasca R and Sportoletti P and Thadani-Mulero M and Cazares O and Huang W and Jiang Y and Clark E and Jin HY and Boyer M and Morschhauser F},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025030630},
  url = {https://doi.org/10.1182/blood.2025030630}
}

RIS

TY  - JOUR
TI  - Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.
AU  - Sharman JP
AU  - Laurenti L
AU  - Ferrant E
AU  - Casado Montero LF
AU  - Mulligan SP
AU  - Harrup R
AU  - Opat S
AU  - Ibatici A
AU  - Marasca R
AU  - Sportoletti P
AU  - Thadani-Mulero M
AU  - Cazares O
AU  - Huang W
AU  - Jiang Y
AU  - Clark E
AU  - Jin HY
AU  - Boyer M
AU  - Morschhauser F
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2025030630
UR  - https://doi.org/10.1182/blood.2025030630
ER  -

APA

JP, S., L, L., E, F., LF, C. M., SP, M., R, H., S, O., A, I., R, M., P, S., M, T., O, C., W, H., Y, J., E, C., HY, J., M, B., & F, M. (2026). Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.. Blood. https://doi.org/10.1182/blood.2025030630

Source records

pubmed · retrieved 2026-09-27T10:51:36.405Z